Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 2 |
| Jun 2026 | 1 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2024 Filed Mar 7, 2024 22:46 UTC |
Horgen Jay C.Director · President and CEO
|
Exercise / conversionStock Units · Derivative | 12,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009061 · form4.xml · derivative · entry 5 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,918 Underlying: Common Stock · 12,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:46 UTC |
Horgen Jay C.Director · President and CEO
|
Tax withholdingCommon Stock | 14,281 | $158.58 | $2,264,680.98 |
DisclosureSEC source: 0001127602-24-009061 · form4.xml · nonDerivative · entry 3 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,004 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the awards described above. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:46 UTC |
Horgen Jay C.Director · President and CEO
|
GrantCommon Stock | 22,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009061 · form4.xml · nonDerivative · entry 2 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,285 F2 · price: Award granted in March 2021, which settled following the achievement of performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:46 UTC |
Horgen Jay C.Director · President and CEO
|
Exercise / conversionCommon Stock | 12,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009061 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:44 UTC |
Jamal Rizwan MHead of Affiliate Investments
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 428,807 | $0.00 Strike: $74.49 | $0.00 |
DisclosureSEC source: 0001127602-24-009059 · form4.xml · derivative · entry 7 Jamal Rizwan M · CIK 0001890565 · Head of Affiliate Investments 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,807 Underlying: Common Stock · 428,807 shares Expires 2026-08-15 F5 · derivative.exercise_date: Reflects an option award granted in August 2019, which vests on August 15, 2024 following the satisfaction of applicable performance and service conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:44 UTC |
Jamal Rizwan MHead of Affiliate Investments
|
GrantStock Units · Derivative | 6,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009059 · form4.xml · derivative · entry 6 Jamal Rizwan M · CIK 0001890565 · Head of Affiliate Investments 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,432 Underlying: Common Stock · 6,432 shares Expires not disclosed F4 · derivative.exercise_price: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. F4 · derivative.exercise_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. F4 · derivative.expiration_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:44 UTC |
Jamal Rizwan MHead of Affiliate Investments
|
Exercise / conversionStock Units · Derivative | 6,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009059 · form4.xml · derivative · entry 5 Jamal Rizwan M · CIK 0001890565 · Head of Affiliate Investments 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,834 Underlying: Common Stock · 6,687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:44 UTC |
Jamal Rizwan MHead of Affiliate Investments
|
Tax withholdingCommon Stock | 9,650 | $158.58 | $1,530,297.00 |
DisclosureSEC source: 0001127602-24-009059 · form4.xml · nonDerivative · entry 3 Jamal Rizwan M · CIK 0001890565 · Head of Affiliate Investments 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,496 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the awards described above. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:44 UTC |
Jamal Rizwan MHead of Affiliate Investments
|
GrantCommon Stock | 13,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009059 · form4.xml · nonDerivative · entry 2 Jamal Rizwan M · CIK 0001890565 · Head of Affiliate Investments 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,146 F2 · price: Award granted in March 2021, which settled following the achievement of performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:44 UTC |
Jamal Rizwan MHead of Affiliate Investments
|
Exercise / conversionCommon Stock | 6,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009059 · form4.xml · nonDerivative · entry 1 Jamal Rizwan M · CIK 0001890565 · Head of Affiliate Investments 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:41 UTC |
Wojcik Thomas MChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 373,145 | $0.00 Strike: $74.49 | $0.00 |
DisclosureSEC source: 0001127602-24-009057 · form4.xml · derivative · entry 6 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,145 Underlying: Common Stock · 373,145 shares Expires 2026-08-15 F5 · derivative.exercise_date: Reflects an option award granted in August 2019, which vests on August 15, 2024 following the satisfaction of applicable performance and service conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:41 UTC |
Wojcik Thomas MChief Financial Officer
|
GrantStock Units · Derivative | 6,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009057 · form4.xml · derivative · entry 5 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,432 Underlying: Common Stock · 6,432 shares Expires not disclosed F4 · derivative.exercise_price: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. F4 · derivative.exercise_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. F4 · derivative.expiration_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2025, 2026, 2027, and 2028. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:41 UTC |
Wojcik Thomas MChief Financial Officer
|
Exercise / conversionStock Units · Derivative | 5,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009057 · form4.xml · derivative · entry 4 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,773 Underlying: Common Stock · 5,678 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:41 UTC |
Wojcik Thomas MChief Financial Officer
|
Tax withholdingCommon Stock | 9,778 | $158.58 | $1,550,595.24 |
DisclosureSEC source: 0001127602-24-009057 · form4.xml · nonDerivative · entry 3 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,167 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the awards described above. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:41 UTC |
Wojcik Thomas MChief Financial Officer
|
GrantCommon Stock | 13,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009057 · form4.xml · nonDerivative · entry 2 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,945 F2 · price: Award granted in March 2021, which settled following the achievement of performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:41 UTC |
Wojcik Thomas MChief Financial Officer
|
Exercise / conversionCommon Stock | 5,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009057 · form4.xml · nonDerivative · entry 1 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:39 UTC |
Ryan David ChristopherDirector
|
Exercise / conversionStock Units · Derivative | 317 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009055 · form4.xml · derivative · entry 2 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,686 Underlying: Common Stock · 317 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2023-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2023-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2023-2027. F2 · balance_after: Inclusive of previously reported deferred stock units. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:39 UTC |
Ryan David ChristopherDirector
|
Exercise / conversionCommon Stock | 317 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009055 · form4.xml · nonDerivative · entry 1 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2023-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:37 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionStock Units · Derivative | 555 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009053 · form4.xml · derivative · entry 2 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,205 Underlying: Common Stock · 555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F2 · balance_after: Inclusive of previously reported deferred stock units. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:37 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionCommon Stock | 555 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009053 · form4.xml · nonDerivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:36 UTC |
Matos Rodriguez Felix V.Director
|
Exercise / conversionStock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009051 · form4.xml · derivative · entry 2 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,293 Underlying: Common Stock · 525 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:36 UTC |
Matos Rodriguez Felix V.Director
|
Exercise / conversionCommon Stock | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009051 · form4.xml · nonDerivative · entry 1 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:34 UTC |
Jeffery Reuben IIIDirector
|
Exercise / conversionStock Units · Derivative | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009047 · form4.xml · derivative · entry 2 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:34 UTC |
Jeffery Reuben IIIDirector
|
Exercise / conversionCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009047 · form4.xml · nonDerivative · entry 1 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:33 UTC |
Churchill Dwight D.Director
|
Exercise / conversionStock Units · Derivative | 840 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009043 · form4.xml · derivative · entry 2 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,429 Underlying: Common Stock · 840 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:33 UTC |
Churchill Dwight D.Director
|
Exercise / conversionCommon Stock | 840 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009043 · form4.xml · nonDerivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:31 UTC |
Alvingham Karen L.Director
|
Exercise / conversionStock Units · Derivative | 537 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009041 · form4.xml · derivative · entry 3 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Stock · 537 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F3 · balance_after: Inclusive of previously reported deferred stock units. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:31 UTC |
Alvingham Karen L.Director
|
Tax withholdingCommon Stock | 41 | $158.58 | $6,501.78 |
DisclosureSEC source: 0001127602-24-009041 · form4.xml · nonDerivative · entry 2 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,262 F2 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the settlement of the awards described above. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:31 UTC |
Alvingham Karen L.Director
|
Exercise / conversionCommon Stock | 537 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009041 · form4.xml · nonDerivative · entry 1 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:29 UTC |
Atkinson Tracy ADirector
|
Exercise / conversionStock Units · Derivative | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009038 · form4.xml · derivative · entry 2 Atkinson Tracy A · CIK 0001338351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,609 Underlying: Common Stock · 544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:29 UTC |
Atkinson Tracy ADirector
|
Exercise / conversionCommon Stock | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009038 · form4.xml · nonDerivative · entry 1 Atkinson Tracy A · CIK 0001338351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:27 UTC |
Atkinson Tracy ADirector
|
GrantRestricted Stock Units · Derivative | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003756 · form4.xml · derivative · entry 1 Atkinson Tracy A · CIK 0001338351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 Underlying: Common Stock · 638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:25 UTC |
Churchill Dwight D.Director
|
GrantRestricted Stock Units · Derivative | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003753 · form4.xml · derivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692 Underlying: Common Stock · 692 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:23 UTC |
Jeffery Reuben IIIDirector
|
GrantRestricted Stock Units · Derivative | 904 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003752 · form4.xml · derivative · entry 1 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 904 Underlying: Common Stock · 904 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:22 UTC |
Matos Rodriguez Felix V.Director
|
GrantRestricted Stock Units · Derivative | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003751 · form4.xml · derivative · entry 1 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 Underlying: Common Stock · 638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:20 UTC |
Alvingham Karen L.Director
|
GrantRestricted Stock Units · Derivative | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003750 · form4.xml · derivative · entry 2 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 Underlying: Common Stock · 638 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F2 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:20 UTC |
Alvingham Karen L.Director
|
GrantDeferred Stock Units · Derivative | 309 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003750 · form4.xml · derivative · entry 1 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309 Underlying: Common Stock · 309 shares Expires not disclosed F1 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F1 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F1 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:17 UTC |
Palandjian Tracy P.Director
|
GrantRestricted Stock Units · Derivative | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003746 · form4.xml · derivative · entry 2 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 Underlying: Common Stock · 638 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F2 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:17 UTC |
Palandjian Tracy P.Director
|
GrantDeferred Stock Units · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003746 · form4.xml · derivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372 Underlying: Common Stock · 372 shares Expires not disclosed F1 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F1 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F1 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:14 UTC |
Ryan David ChristopherDirector
|
GrantRestricted Stock Units · Derivative | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003740 · form4.xml · derivative · entry 2 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 Underlying: Common Stock · 638 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F2 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:14 UTC |
Ryan David ChristopherDirector
|
GrantDeferred Stock Units · Derivative | 318 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003740 · form4.xml · derivative · entry 1 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318 Underlying: Common Stock · 318 shares Expires not disclosed F1 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F1 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F1 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:11 UTC |
STARR LOREN MDirector
|
GrantRestricted Stock Units · Derivative | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003735 · form4.xml · derivative · entry 2 STARR LOREN M · CIK 0001217495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 Underlying: Common Stock · 638 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F2 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on March 5, 2025. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:11 UTC |
STARR LOREN MDirector
|
GrantDeferred Stock Units · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003735 · form4.xml · derivative · entry 1 STARR LOREN M · CIK 0001217495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308 Underlying: Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F1 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F1 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:39 UTC |
Horgen Jay C.Director · President and CEO
|
Exercise / conversionStock Units · Derivative | 5,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000570 · form4.xml · derivative · entry 4 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,685 Underlying: Common Stock · 5,792 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of a previously reported award. Award vests 2021-2024. F1 · derivative.exercise_date: Reflects the vesting of a previously reported award. Award vests 2021-2024. F1 · derivative.expiration_date: Reflects the vesting of a previously reported award. Award vests 2021-2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:39 UTC |
Horgen Jay C.Director · President and CEO
|
Tax withholdingCommon Stock | 2,365 | $151.42 | $358,108.30 |
DisclosureSEC source: 0001127602-24-000570 · form4.xml · nonDerivative · entry 2 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,907 F2 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the award described above. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:39 UTC |
Horgen Jay C.Director · President and CEO
|
Exercise / conversionCommon Stock | 5,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000570 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of a previously reported award. Award vests 2021-2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:36 UTC |
Wojcik Thomas MChief Financial Officer
|
Exercise / conversionStock Units · Derivative | 2,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000568 · form4.xml · derivative · entry 3 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,451 Underlying: Common Stock · 2,642 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of a previously reported award. Award vests 2021-2024. F1 · derivative.exercise_date: Reflects the vesting of a previously reported award. Award vests 2021-2024. F1 · derivative.expiration_date: Reflects the vesting of a previously reported award. Award vests 2021-2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:36 UTC |
Wojcik Thomas MChief Financial Officer
|
Tax withholdingCommon Stock | 1,399 | $151.42 | $211,836.58 |
DisclosureSEC source: 0001127602-24-000568 · form4.xml · nonDerivative · entry 2 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,861 F2 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the award described above. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:36 UTC |
Wojcik Thomas MChief Financial Officer
|
Exercise / conversionCommon Stock | 2,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000568 · form4.xml · nonDerivative · entry 1 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of a previously reported award. Award vests 2021-2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:34 UTC |
Jamal Rizwan MHead of Affiliate Investments
|
Exercise / conversionStock Units · Derivative | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000567 · form4.xml · derivative · entry 4 Jamal Rizwan M · CIK 0001890565 · Head of Affiliate Investments 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,521 Underlying: Common Stock · 2,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of a previously reported award. Award vests 2021-2024. F1 · derivative.exercise_date: Reflects the vesting of a previously reported award. Award vests 2021-2024. F1 · derivative.expiration_date: Reflects the vesting of a previously reported award. Award vests 2021-2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.